InvestorsHub Logo
Followers 861
Posts 28265
Boards Moderated 1
Alias Born 03/16/2014

Re: Never_Post post# 253916

Saturday, 03/17/2018 1:25:30 PM

Saturday, March 17, 2018 1:25:30 PM

Post# of 290029
I just listened to the conference call and noticed DP threw around the term "optics" a few times as well

It is coincidental for sure, but then again the same thing happened during the last conference call, too:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136134581

Maybe we both just think similarly about certain aspects of TRTC and why its stock price should be higher given its accomplishments relative to everybody else (public companies) in America

---

This conference call was different from all of the others I have listened to over the years

DP sounds like he is ready to dominate in 2018

I think it could take several weeks or even months to see whether the optics hypothesis has legs, or we could find out as soon as next week

One thing is for certain -- TRTC diluted itself from 300M to 1B shares in just 2 years and if you calculated the 2 year VWAP, the stock moved pretty much sideways during that time period -- that is very bullish for future price action, particularly if the rate of dilution will decrease and the optics will significantly improve moving forward

The reverse split accomplishes both of those objectives

We saw the same phenomenon in 2015 with TRTC putting in a firm bottom btwn .08 - .12 during the past 6 months of 2015 despite the double whammy of heavy dilution from Magna and Dominion -- that was a huge signal to me to go really heavy on TRTC for the anticipated 2016 runup

One final point that many seem to gloss over -- 2017 was ruined by the combination of 100M shares being sold from the Blum Oakland acquisition simultaneous with the total destruction of the MJ sector in a year with zero sector catalysts (other than Nevada starting Rec MJ sales in July)

2018 is filled with sector catalysts -- just because Sessions ruined the California catalyst doesn't change the fact that he can't ruin many of the remaining catalysts -- particularly the 6/27/18 Epidiolex (MJ-derived CBD) approval by the FDA, which automatically triggers a rescheduling of CBD, most likely to Schedule IV/V to protect Big Pharma, even though it should be removed entirely from the schedule

This will be the 1st time the federal government admits that MJ has medical value

That is an historically game-changing development that is extremely likely to trigger another mania


Sleek

$LEEK$CAPE'$ GRAND SALAMI FOR 2018 MARIJUANA MANIA -- PART II
http://investorshub.advfn.com/$LEEK$CAPE$-GRAND-SALAMI-FOR-2018-MARIJUANA-MANIA-PART-II-31243/